Hematologic and immunologic studies in dogs given nitrogen mustard (hn3)

Area of Science:

• Toxicology
• Immunology
• Hematology

Background:

• Nitrogen mustard (HN3) is a potent alkylating agent with known cytotoxic effects.
• Understanding HN3's impact on hematologic and immune systems is crucial for managing potential exposures and developing therapeutic strategies.

Purpose of the Study:

• To evaluate the hematologic and immunosuppressive effects of single-dose nitrogen mustard (HN3) administration in dogs.
• To assess the recovery patterns of peripheral blood counts and immune cell function following HN3 treatment.

Main Methods:

• Twenty dogs received single doses of HN3.
• Peripheral blood counts (white blood cells, platelets, lymphocytes) were monitored.
• Bone marrow granulopoietic progenitor cells (CFU-C) were assayed using in vitro culture.
• Cellular immune function was assessed by lymphocyte proliferation in response to mitogens.
• Humoral immune function was evaluated by antibody formation against sheep red blood cells.

Main Results:

• HN3 caused profound depression of peripheral blood counts in all dogs.
• White blood cell count recovery was complete by day 15 in surviving dogs.
• Platelet and lymphocyte counts showed prolonged recovery.
• Bone marrow CFU-C levels decreased significantly one day post-treatment but rapidly restored to normal within 4-7 days at near-lethal doses.
• Cellular and humoral immune functions were impaired long-term, with reduced lymphocyte proliferation and delayed antibody formation.

Conclusions:

• HN3 induces significant hematologic toxicity and immunosuppression in dogs.
• Recovery kinetics differ between myeloid progenitor cells and lymphoid precursor cells.
• Results suggest distinct effects of HN3 on lymphoid versus myeloid precursor cells, impacting immune reconstitution.